Exploring Analyst Estimates for Dentsply (XRAY) Q4 Earnings, Beyond Revenue and EPS

Wall Street analysts forecast that Dentsply International (XRAY) will report quarterly earnings of $0.28 per share in its upcoming release, pointing to a year-over-year increase of 7.7%. It is anticipated that revenues will amount to $920.05 million, exhibiting an increase of 1.7% compared to the year-ago quarter.The consensus EPS estimate for the quarter has been revised 4% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.That said, let's delve into the average estimates of some Dentsply metrics that Wall Street analysts commonly model and monitor.Analysts predict that the 'Net sales- Essential Dental Solutions' will reach $348.19 million. The estimate indicates a change of +0.6% from the prior-year quarter.Analysts' assessment points toward 'Net sales- Orthodontic and Implant Solutions' reaching $196.84 million. The estimate indicates a change of +6.4% from the prior-year quarter.According to the collective judgment of analysts, 'Net sales- Connected Technology Solutions' should come in at $284.22 million. The estimate indicates a change of -3% from the prior-year quarter.The combined assessment of analysts suggests that 'Net sales- Wellspect Healthcare' will likely reach $86.48 million. The estimate indicates a change of +6.8% from the prior-year quarter.Based on the collective assessment of analysts, 'Net sales- Orthodontic and Implant Solutions- Implants & Prosthetics' should arrive at $161.59 million. The estimate suggests a change of -0.3% year over year.The collective assessment of analysts points to an estimated 'Net sales- Connected Technology Solutions- CAD/CAM' of $128.39 million. The estimate indicates a year-over-year change of -9.6%.Analysts forecast 'Net sales- Connected Technology Solutions- Equipment & Instruments' to reach $161.37 million. The estimate indicates a change of +6.9% from the prior-year quarter.The consensus among analysts is that 'Net sales- Orthodontic and Implant Solutions- Orthodontics' will reach $35.14 million. The estimate indicates a change of +52.8% from the prior-year quarter.Analysts expect 'Revenues- United States' to come in at $264.91 million. The estimate indicates a year-over-year change of +2.3%.It is projected by analysts that the 'Revenues- Rest of World' will reach $242.88 million. The estimate points to a change of +2.1% from the year-ago quarter.The consensus estimate for 'Revenues- Europe' stands at $420.19 million. The estimate points to a change of +3% from the year-ago quarter.The average prediction of analysts places 'Adjusted Operating Income- Connected Technology Solutions' at $20.97 million. Compared to the current estimate, the company reported $49.00 million in the same quarter of the previous year. View all Key Company Metrics for Dentsply here>>> Shares of Dentsply have experienced a change of +2.9% in the past month compared to the -0.3% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), XRAY is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report DENTSPLY SIRONA Inc. (XRAY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks